Abstract
Novel Agents May be Preferable to Chemotherapy for Large B-Cell Lymphoma Progressing after CD19-CAR-T: A Multicenter Observational Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have